Low-Dose-Rate Irradiation by 131I Versus High-Dose-Rate External-Beam Irradiation in the Rat Pancreatic Tumor Cell Line CA20948-Reference-Cited by-同舟云学术

Low-Dose-Rate Irradiation by 131I Versus High-Dose-Rate External-Beam Irradiation in the Rat Pancreatic Tumor Cell Line CA20948

Published:2004-06 Issue:3 Volume:19 Page:285-292
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Verwijnen Suzanne¹,Capello Astrid¹,Bernard Bert¹,van den Aardweg Gerard²,Konijnenberg Mark³,Breeman Wout¹,Krenning Eric¹,de Jong Marion¹

Affiliation:

1. Department of Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands

2. Department of Radiation Oncology, Erasmus MC, Rotterdam, The Netherlands

3. Mallinckrodt Medical BV, Tyco Healthcare, Petten, The Netherlands

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/1084978041425098

Reference37 articles.

1. [177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy

2. Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount

3. Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings

4. Novel Receptor-Targeted Fluorescent Contrast Agents for In Vivo Tumor Imaging

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Vivo Efficacy Testing of Peptide Receptor Radionuclide Therapy Radiosensitization Using Olaparib;Cancers;2023-02-01

2. A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT);Pharmaceutics;2022-09-22

3. Radio-enhancement effects by radiolabeled nanoparticles;Scientific Reports;2019-10-04

4. In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy;PLOS ONE;2017-07-21

5. Optimizing labelling conditions of 213Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy;EJNMMI Radiopharmacy and Chemistry;2016-05-14